Important Considerations Related to Permeability of Peptides
This review on intracellular delivery and oral bioavailability of peptides reflects a number of principal investigations at Novartis. Our studies were aimed at either understanding features enabling peptides to interfere with intracellular protein–protein interactions, or to achieve a more patient-friendly delivery by the oral route. In the light of these objectives, we have also spent some effort on assay development to come up with alternative methods for monitoring cellular peptide uptake. This summary of our insights is intended to help in the assessment and development of peptide therapeutics requiring membrane transition.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:75 |
|---|---|
| Enthalten in: |
CHIMIA - 75(2021), 6, Seite 522-524 |
| Sprache: |
Deutsch ; Englisch ; Französisch |
|---|
| Beteiligte Personen: |
Thomas E. Vorherr [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Chemistry |
|---|
| doi: |
10.2533/chimia.2021.522 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ056656769 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ056656769 | ||
| 003 | DE-627 | ||
| 005 | 20230308203152.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2021 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.2533/chimia.2021.522 |2 doi | |
| 035 | |a (DE-627)DOAJ056656769 | ||
| 035 | |a (DE-599)DOAJabba6a6ec828420eaff742e6be9dbe35 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger |a eng |a fre | ||
| 050 | 0 | |a QD1-999 | |
| 100 | 0 | |a Thomas E. Vorherr |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Important Considerations Related to Permeability of Peptides |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a This review on intracellular delivery and oral bioavailability of peptides reflects a number of principal investigations at Novartis. Our studies were aimed at either understanding features enabling peptides to interfere with intracellular protein–protein interactions, or to achieve a more patient-friendly delivery by the oral route. In the light of these objectives, we have also spent some effort on assay development to come up with alternative methods for monitoring cellular peptide uptake. This summary of our insights is intended to help in the assessment and development of peptide therapeutics requiring membrane transition | ||
| 650 | 4 | |a intracellular delivery | |
| 650 | 4 | |a metabolism | |
| 650 | 4 | |a oral bioavailability | |
| 650 | 4 | |a permeability | |
| 650 | 4 | |a pharmacokinetics | |
| 653 | 0 | |a Chemistry | |
| 773 | 0 | 8 | |i In |t CHIMIA |d Swiss Chemical Society, 2020 |g 75(2021), 6, Seite 522-524 |w (DE-627)DOAJ000148156 |x 26732424 |7 nnns |
| 773 | 1 | 8 | |g volume:75 |g year:2021 |g number:6 |g pages:522-524 |
| 856 | 4 | 0 | |u https://doi.org/10.2533/chimia.2021.522 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/abba6a6ec828420eaff742e6be9dbe35 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.ingentaconnect.com/contentone/scs/chimia/2021/00000075/00000006/art00012 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/0009-4293 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2673-2424 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 75 |j 2021 |e 6 |h 522-524 | ||